Unity Biotechnology, Inc. (LON: 0YC0)
London
· Delayed Price · Currency is GBP · Price in USD 2.570
+0.700 (37.43%)
Jan 23, 2025, 5:41 PM BST
Unity Biotechnology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
19
Market Cap
28.59M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |
Unity Biotechnology News
- 15 days ago - UNITY Biotechnology Reports Granting of New Employment Inducement Award - GlobeNewsWire
- 17 days ago - Unity Biotechnology gets new chief medical officer - Seeking Alpha
- 17 days ago - UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer - GlobeNewsWire
- 2 months ago - UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 6 months ago - UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 6 months ago - UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer - GlobeNewsWire
- 9 months ago - UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 9 months ago - UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting - GlobeNewsWire